Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 1994. Start Trial.
Date Value
September 30, 2026 82.43%
August 31, 2026 82.43%
July 31, 2026 82.43%
June 30, 2026 82.43%
May 31, 2026 82.43%
April 30, 2026 82.43%
March 31, 2026 82.43%
February 28, 2026 82.43%
January 31, 2026 82.43%
December 31, 2025 82.43%
November 30, 2025 82.43%
October 31, 2025 82.43%
September 30, 2025 82.43%
August 31, 2025 82.43%
July 31, 2025 79.21%
June 30, 2025 74.40%
May 31, 2025 74.40%
April 30, 2025 74.40%
March 31, 2025 74.40%
February 28, 2025 74.40%
January 31, 2025 74.40%
December 31, 2024 74.40%
November 30, 2024 74.40%
October 31, 2024 74.40%
September 30, 2024 74.40%
Date Value
August 31, 2024 74.40%
July 31, 2024 74.40%
June 30, 2024 74.40%
May 31, 2024 74.40%
April 30, 2024 74.40%
March 31, 2024 74.40%
February 29, 2024 74.40%
January 31, 2024 74.40%
December 31, 2023 74.40%
November 30, 2023 74.40%
October 31, 2023 71.59%
September 30, 2023 68.42%
August 31, 2023 64.25%
July 31, 2023 64.25%
June 30, 2023 64.25%
May 31, 2023 64.25%
April 30, 2023 64.25%
March 31, 2023 64.25%
February 28, 2023 64.25%
January 31, 2023 64.25%
December 31, 2022 64.25%
November 30, 2022 64.25%
October 31, 2022 64.25%
September 30, 2022 57.91%
August 31, 2022 49.39%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Lifecore Biomedical, Inc. 89.19%
Repligen Corp. 68.27%
Bio-Techne Corp. 67.22%
Codexis, Inc. 97.65%
MetaStat, Inc. 100.00%